AMERICAN ASSOCIATION OF EXTRACELLULAR VESICLES INC (EIN 873458570) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

Ke Cheng

Phone

9195619480

Tax Period

2025-01-01 to 2025-12-31

AMERICAN ASSOCIATION OF EXTRACELLULAR VESICLES INC, founded in 2021, is a small nonprofit in the Medical Research sector that reported $269K in total revenue in fiscal year 2025. Revenue grew 14% year-over-year, indicating healthy expansion. The organization ran a surplus of $110K, a strong 41% operating margin.

Mission

The purpose of the Association is to promote the development, dissemination, integration, and utilization of knowledge in the field of extracellular vesicles. The Association provides a platform for researchers to learn, disseminate, and network with extracellular vesicles researchers worldwide through Annual Conferences, peer-reviewed journal, initiatives, and industry partnerships.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $268,882

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $268,882

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $158,675

Other Expenses $158,675

TOTAL EXPENSES $158,675

Year-over-Year Comparison

	2025	2024	Change
Revenue	$268,882	$236,618	+0.1%
Expenses	$158,675	$132,715	+0.2%
Net Income	$110,207	$103,903	+0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

N/A

Independent Members

N/A

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Ke Cheng	Board of Directors	5.00	Key Emp	$0	$0	$0
Raghu Kalluri	President	5.00	Key Emp	$0	$0	$0
Shiqi Hu	Program Manager	10.00	Officer	$0	$0	$0
Kaiyue Zhang	Program Coordinator	10.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$268,882	$158,675	$242,727	$110,207
2024	$236,618	$132,715	$132,520	$103,903

AMERICAN ASSOCIATION OF EXTRACELLULAR VESICLES INC